IRIS Accounts Production v24.3.0.553 09188127 Board of Directors 1.9.23 31.8.24 31.8.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh091881272023-08-31091881272024-08-31091881272023-09-012024-08-31091881272022-08-31091881272022-09-012023-08-31091881272023-08-3109188127ns15:EnglandWales2023-09-012024-08-3109188127ns14:PoundSterling2023-09-012024-08-3109188127ns10:Director12023-09-012024-08-3109188127ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3109188127ns10:SmallEntities2023-09-012024-08-3109188127ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3109188127ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3109188127ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3109188127ns10:FullAccounts2023-09-012024-08-3109188127ns10:OrdinaryShareClass12023-09-012024-08-3109188127ns10:OrdinaryShareClass22023-09-012024-08-3109188127ns10:OrdinaryShareClass32023-09-012024-08-3109188127ns5:CurrentFinancialInstruments2024-08-3109188127ns5:CurrentFinancialInstruments2023-08-3109188127ns5:ShareCapital2024-08-3109188127ns5:ShareCapital2023-08-3109188127ns5:RetainedEarningsAccumulatedLosses2024-08-3109188127ns5:RetainedEarningsAccumulatedLosses2023-08-3109188127ns10:RegisteredOffice2023-09-012024-08-3109188127ns5:FurnitureFittings2023-09-012024-08-3109188127ns5:MotorVehicles2023-09-012024-08-3109188127ns5:ComputerEquipment2023-09-012024-08-3109188127ns5:FurnitureFittings2023-08-3109188127ns5:MotorVehicles2023-08-3109188127ns5:ComputerEquipment2023-08-3109188127ns5:FurnitureFittings2024-08-3109188127ns5:MotorVehicles2024-08-3109188127ns5:ComputerEquipment2024-08-3109188127ns5:FurnitureFittings2023-08-3109188127ns5:MotorVehicles2023-08-3109188127ns5:ComputerEquipment2023-08-3109188127ns5:DeferredTaxation2023-08-3109188127ns5:DeferredTaxation2023-09-012024-08-3109188127ns5:DeferredTaxation2024-08-3109188127ns10:OrdinaryShareClass12024-08-3109188127ns10:OrdinaryShareClass22024-08-3109188127ns10:OrdinaryShareClass32024-08-3109188127ns10:Director22023-09-012024-08-3109188127ns10:Director222023-08-3109188127ns10:Director222022-08-3109188127ns10:Director222023-09-012024-08-3109188127ns10:Director222022-09-012023-08-3109188127ns10:Director222024-08-3109188127ns10:Director222023-08-31
REGISTERED NUMBER: 09188127 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 August 2024

for

MB Cardiac Consulting Ltd

MB Cardiac Consulting Ltd (Registered number: 09188127)






Contents of the Financial Statements
for the Year Ended 31 August 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


MB Cardiac Consulting Ltd (Registered number: 09188127)

Balance Sheet
31 August 2024

31.8.24 31.8.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 6,050 6,774

CURRENT ASSETS
Debtors 5 - 9,704
Investments 6 207,047 179,325
Cash at bank 156,833 191,201
363,880 380,230
CREDITORS
Amounts falling due within one year 7 316 6,746
NET CURRENT ASSETS 363,564 373,484
TOTAL ASSETS LESS CURRENT
LIABILITIES

369,614

380,258

PROVISIONS FOR LIABILITIES 8 1,150 1,355
NET ASSETS 368,464 378,903

CAPITAL AND RESERVES
Called up share capital 9 101 101
Retained earnings 368,363 378,802
SHAREHOLDERS' FUNDS 368,464 378,903

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MB Cardiac Consulting Ltd (Registered number: 09188127)

Balance Sheet - continued
31 August 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 November 2024 and were signed on its behalf by:





Mrs A Sirry - Director


MB Cardiac Consulting Ltd (Registered number: 09188127)

Notes to the Financial Statements
for the Year Ended 31 August 2024

1. STATUTORY INFORMATION

MB Cardiac Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 09188127

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
Oxford Street
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on cost
Motor vehicles - 20% on reducing balance
Computer equipment - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MB Cardiac Consulting Ltd (Registered number: 09188127)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 September 2023 22,908 50,740 10,560 84,208
Additions 4,943 - - 4,943
Disposals (18,457 ) - - (18,457 )
At 31 August 2024 9,394 50,740 10,560 70,694
DEPRECIATION
At 1 September 2023 18,246 50,740 8,448 77,434
Charge for year 2,498 - 2,112 4,610
Eliminated on disposal (17,400 ) - - (17,400 )
At 31 August 2024 3,344 50,740 10,560 64,644
NET BOOK VALUE
At 31 August 2024 6,050 - - 6,050
At 31 August 2023 4,662 - 2,112 6,774

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Trade debtors - 9,704

MB Cardiac Consulting Ltd (Registered number: 09188127)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2024

6. CURRENT ASSET INVESTMENTS
31.8.24 31.8.23
£    £   
Listed investments 207,047 179,325
Market value of listed investments at 31 August 2024 - £ 207,047 (2023 - £ 179,325 ).

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Trade creditors - 1
Tax (3,832 ) 4,216
Social security and other taxes 80 80
Directors' current accounts 3,588 1,711
Accrued expenses 480 738
316 6,746

8. PROVISIONS FOR LIABILITIES
31.8.24 31.8.23
£    £   
Deferred tax 1,150 1,355

Deferred
tax
£   
Balance at 1 September 2023 1,355
Utilised during year (205 )
Balance at 31 August 2024 1,150

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.8.24 31.8.23
value: £    £   
60 Ordinary A £1 60 60
40 Ordinary B £1 40 40
1 Ordinary C £1 1 1
101 101

MB Cardiac Consulting Ltd (Registered number: 09188127)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2024

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 August 2024 and 31 August 2023:

31.8.24 31.8.23
£    £   
Dr M M H Baghai
Balance outstanding at start of year (1,710 ) (1,917 )
Amounts advanced 434 5,519
Amounts repaid (2,312 ) (5,312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (3,588 ) (1,710 )

11. ULTIMATE CONTROLLING PARTY

The controlling party is Dr M M H Baghai.